197 related articles for article (PubMed ID: 23857458)
1. High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.
Fendler WP; Melzer HI; Walz C; von Schweinitz D; Coppenrath E; Schmid I; Bartenstein P; Pfluger T
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1701-10. PubMed ID: 23857458
[TBL] [Abstract][Full Text] [Related]
2. Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy.
Fendler WP; Wenter V; Thornton HI; Ilhan H; von Schweinitz D; Coppenrath E; Schmid I; Bartenstein P; Pfluger T
PLoS One; 2015; 10(7):e0132809. PubMed ID: 26177109
[TBL] [Abstract][Full Text] [Related]
3. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Melzer HI; Coppenrath E; Schmid I; Albert MH; von Schweinitz D; Tudball C; Bartenstein P; Pfluger T
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1648-58. PubMed ID: 21617976
[TBL] [Abstract][Full Text] [Related]
4. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
5. Activity of iodine-123 metaiodobenzylguanidine in childhood neuroblastoma: lack of relation to tumour differentiation in vivo.
Brans B; Laureys G; Schelfhout V; Wiele CV; Potter CR; Dhooge C; Simons M; Dierckx RA
Eur J Nucl Med; 1998 Feb; 25(2):144-9. PubMed ID: 9473262
[TBL] [Abstract][Full Text] [Related]
6. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
[TBL] [Abstract][Full Text] [Related]
7. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
8. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
Suga K; Ogasawara N; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
Eur J Nucl Med; 2000 May; 27(5):574-82. PubMed ID: 10853814
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
[TBL] [Abstract][Full Text] [Related]
10. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M
AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459
[TBL] [Abstract][Full Text] [Related]
11. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
12. [Iodine-123-MIBG scintigraphy in neuroblastoma; relationship between the intensity of uptake and tumor characteristics].
Okuyama C; Ushijima Y; Watanabe K; Sugihara H; Nishimura T
Kaku Igaku; 1999 Oct; 36(8):827-34. PubMed ID: 10586543
[TBL] [Abstract][Full Text] [Related]
13. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
14. Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.
Samoyedny A; Srinivasan A; States L; Mosse YP; Alai E; Pawel B; Pogoriler J; Shellikeri S; Vatsky S; Acord M; Escobar F; Edgar JC; Maris JM; Cahill AM
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250393
[TBL] [Abstract][Full Text] [Related]
15. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic imaging in abdominal neuroblastoma: is there a complementary role of MIBG-scintigraphy and ultrasonography?
Petjak M; Tiel-van Buul MM; Staalman CR; Greve JC; de Kraker J; van Royen EA
Eur J Pediatr; 1997 Aug; 156(8):610-5. PubMed ID: 9266191
[TBL] [Abstract][Full Text] [Related]
17. Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients.
van der Palen RL; Bulten BF; Mavinkurve-Groothuis AM; Bellersen L; van Laarhoven HW; Kapusta L; de Geus-Oei LF
Nuklearmedizin; 2013 Dec; 52(6):228-34. PubMed ID: 24045423
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
Hashimoto T; Koizumi K; Nishina T; Abe K
Ann Nucl Med; 2003 Dec; 17(8):633-40. PubMed ID: 14971604
[TBL] [Abstract][Full Text] [Related]
19. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract][Full Text] [Related]
20. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial.
Vik TA; Pfluger T; Kadota R; Castel V; Tulchinsky M; Farto JC; Heiba S; Serafini A; Tumeh S; Khutoryansky N; Jacobson AF
Pediatr Blood Cancer; 2009 Jul; 52(7):784-90. PubMed ID: 19185008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]